Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer
Pancreatic Cancer
ClinicalTrials.gov recordTREATMENT READING
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
Cancer in children and adolescents is rare, although the overall incidence has slowly increased since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of the following pediatric specialists and others to ensure that children receive treatment, supportive care, and rehabilitation to achieve optimal survival and quality of life:
Sources: 1
Primary care physicians.
Pediatric surgeons.
Pathologists.
Pediatric radiation oncologists.
Pediatric medical oncologists and hematologists.
Ophthalmologists.
Rehabilitation specialists.
Pediatric oncology nurses.
Social workers.
Child-life professionals.
Psychologists.
Nutritionists.
For specific information about supportive care for children and adolescents with cancer, see the summaries on Supportive and Palliative Care.
Sources: Supportive and Palliative Care
The American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of children and adolescents with cancer.[2] At these centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate is offered to most patients and their families. Clinical trials for children and adolescents diagnosed with cancer are generally designed to compare potentially better therapy with current standard therapy. Other types of clinical trials test novel therapies when there is no standard therapy for a cancer diagnosis. Most of the progress in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI website.
Sources: 2 · NCI website
Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2020, childhood cancer mortality decreased by more than 50%.[3-5] Childhood and adolescent cancer survivors require close monitoring because side effects of cancer therapy may persist or develop months or years after treatment. For information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors, see Late Effects of Treatment for Childhood Cancer.
Sources: 3 · 5 · Late Effects of Treatment for Childhood Cancer
Childhood cancer is a rare disease, with about 15,000 cases diagnosed annually in the United States in individuals younger than 20 years.[6] The U.S. Rare Diseases Act of 2002 defines a rare disease as one that affects populations smaller than 200,000 people in the United States. Therefore, all pediatric cancers are considered rare.
Sources: 6 · Rare Diseases Act of 2002
The designation of a rare tumor is not uniform among pediatric and adult groups. In adults, rare cancers are defined as those with an annual incidence of fewer than six cases per 100,000 people. They account for up to 24% of all cancers diagnosed in the European Union and about 20% of all cancers diagnosed in the United States.[7,8] In children and adolescents, the designation of a rare tumor is not uniform among international groups, as follows:
A consensus effort between the European Union Joint Action on Rare Cancers and the European Cooperative Study Group for Rare Pediatric Cancers estimated that 11% of all cancers in patients younger than 20 years could be categorized as very rare. This consensus group defined very rare cancers as those with annual incidences of fewer than two cases per 1 million people. However, three additional histologies (thyroid carcinoma, melanoma, and testicular cancer) with incidences of more than two cases per 1 million people were also included in the very rare group due to a lack of knowledge and expertise in the management of these tumors.[9]
Sources: 9
The Children's Oncology Group defines rare pediatric cancers as those listed in the International Classification of Childhood Cancer subgroup XI, which includes thyroid cancers, melanomas and nonmelanoma skin cancers, and multiple types of carcinomas (e.g., adrenocortical carcinomas, nasopharyngeal carcinomas, and most adult-type carcinomas such as breast cancers and colorectal cancers).[10] These diagnoses account for about 5% of the cancers diagnosed in children aged 0 to 14 years and about 27% of the cancers diagnosed in adolescents aged 15 to 19 years.[4] Most cancers in subgroup XI are either melanomas or thyroid cancers, with other cancer types accounting for only 2% of the cancers diagnosed in children aged 0 to 14 years and 9.3% of the cancers diagnosed in adolescents aged 15 to 19 years.
These rare cancers are extremely challenging to study because of the relatively few patients with any individual diagnosis, the predominance of rare cancers in the adolescent population, and the small number of clinical trials for adolescents with rare cancers.
Information about these tumors may also be found in sources relevant to adults with cancer, such as Pancreatic Cancer Treatment and Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment.
Sources: Pancreatic Cancer Treatment · Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment
This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
The outcomes of patients with solid pseudopapillary tumors of the pancreas are excellent, with 10-year survival rates exceeding 95%.[5]
Sources: 5
Treatment options for solid pseudopapillary tumor of the pancreas include the following:
Surgery.
Sources: Surgery
Chemotherapy.
Sources: Chemotherapy
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
Treatment of solid pseudopapillary tumor of the pancreas is primarily surgical. However, preoperative and operative spillage is not unusual.[9] Whipple procedures (pancreaticoduodenectomy) are often necessary, but non-Whipple, pancreatic-sparing resections may be possible with a pancreatico-jejunostomy procedure. Surgery is usually curative, although local recurrences occur in 5% to 15% of cases.[4]
A retrospective review of the Italian Pediatric Rare Tumor Registry identified 43 pediatric patients diagnosed with solid pseudopapillary tumor of the pancreas between 2000 and 2018.[10][Level of evidence C1] The median age at diagnosis was 13.2 years (range, 7–18 years). Only one patient presented with metastatic disease.
Sources: 10 · Level of evidence C1
At follow-up (median, 8.4 years; range, 0–17 years), one recurrence occurred in a patient who had intraoperative rupture, and all patients were alive.
A study identified 38 children aged 0 to 18 years who were diagnosed with pseudopapillary solid tumor of the pancreas between 2008 and 2022 in a German registry.[11] Patients were a median age of 14.5 years at diagnosis (range, 8–18 years), with a female preponderance (81.6%). The pancreatic tail was the most frequent location of the tumor. All patients underwent surgical resection.
Sources: 11
No recurrences occurred during follow-up, although two patients underwent resection with microscopic residual disease.
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
The European Cooperative Study Group for Pediatric Rare Tumors within the PARTNER project (Paediatric Rare Tumours Network - European Registry) has published consensus guidelines for the diagnosis and treatment of childhood pancreatoblastoma.[7]
Sources: 7
Using a multimodality approach, close to 80% of patients can be cured.[2]
Sources: 2
Treatment options for pancreatoblastoma include the following:
Surgery.
Sources: Surgery
Chemotherapy.
Sources: Chemotherapy
Other treatments.
Sources: Other treatments
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
For large, unresectable, or metastatic tumors, preoperative chemotherapy is indicated. Pancreatoblastoma often responds to chemotherapy. A cisplatin-based regimen is usually recommended. The PLADO regimen, which includes cisplatin and doxorubicin, is most commonly used. Treatment is modeled after the management of hepatoblastoma, with two to three cycles of preoperative therapy, followed by resection and adjuvant chemotherapy.[2,4,10,11]
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
Although radiation therapy has been used for unresectable tumors and relapsed cases, its role in the treatment of microscopic disease after surgery has not been defined.[4]
Sources: 4
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
Treatment options for islet cell tumors include the following:
Surgery.
Chemotherapy.
Mammalian target of rapamycin (mTOR) inhibitor therapy.
Treatment of islet cell tumors includes medical therapy for control of the syndrome and complete surgical resection.[6] For patients with malignant tumors and unresectable or metastatic disease, chemotherapy and mTOR inhibitors are recommended.
Sources: 6
The management of these tumors in children follows the consensus guidelines established for adult patients.[3,7] For more information, see Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment.
Sources: 3 · 7 · Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
For information about the treatment of pancreatic carcinoma, see Pancreatic Cancer Treatment.
Sources: Pancreatic Cancer Treatment
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: August 13, 2024. Captured 2026-09-09.
Information about National Cancer Institute (NCI)–supported clinical trials can be found on the NCI website. For information about clinical trials sponsored by other organizations, see the ClinicalTrials.gov website.
Sources: NCI website · ClinicalTrials.gov website
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
There are different types of treatment for children with pancreatic cancer.
Children with pancreatic cancer should have their treatment planned by a team of doctors who are experts in treating childhood cancer.
Three types of standard treatment are used:
Three types of standard treatment are used:
Surgery
Chemotherapy
Targeted therapy
New types of treatment are being tested in clinical trials.
Treatment for childhood pancreatic cancer may cause side effects.
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up tests may be needed.
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment.
Sources: standard · clinical trials · research study
Because cancer in children is rare, taking part in a clinical trial should be considered. Some clinical trials are open only to patients who have not started treatment.
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
Treatment will be overseen by a pediatric oncologist, a doctor who specializes in treating children with cancer. The pediatric oncologist works with other pediatric health professionals who are experts in treating children with cancer and who specialize in certain areas of medicine. This may include the following specialists and others:
Sources: pediatric oncologist · cancer · pediatric · medicine · specialists
Pediatrician.
Sources: Pediatrician
Pediatric surgeon.
Sources: Pediatric surgeon
Pathologist.
Sources: Pathologist
Endocrinologist.
Sources: Endocrinologist
Pediatric nurse specialist.
Sources: Pediatric nurse specialist
Social worker.
Sources: Social worker
Rehabilitation specialist.
Sources: Rehabilitation specialist
Psychologist.
Sources: Psychologist
Child-life specialist.
Sources: Child-life specialist
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
Surgery to remove the tumor is used to treat most types of pancreatic cancer. For cancer in the head of the pancreas, a Whipple procedure may be done.
Sources: Surgery · tumor · pancreatic cancer · pancreas · Whipple procedure
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy).
Sources: Chemotherapy · drugs · cells · injected · vein · systemic chemotherapy
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells. Targeted therapies usually cause less harm to normal cells than chemotherapy or radiation therapy do.
Sources: Targeted therapy · radiation therapy
mTOR inhibitor therapy: mTOR inhibitor drugs stop the protein that helps cells divide and survive. This type of drug is used to treat islet cell tumors and is being studied to treat pancreatic carcinoma.
Sources: mTOR inhibitor · therapy · protein · islet cell tumors · pancreatic · carcinoma
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
Information about clinical trials is available from the NCI website.
Sources: clinical trials · NCI website
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
To learn more about side effects that begin during treatment for cancer, visit Side Effects.
Sources: side effects · Side Effects
Side effects from cancer treatment that begin after treatment and continue for months or years are called late effects. Late effects of cancer treatment may include:
Sources: late effects
Physical problems.
Changes in mood, feelings, thinking, learning, or memory.
Second cancers (new types of cancer) or other conditions.
Sources: Second cancers · conditions
Some late effects may be treated or controlled. It is important to talk with your child's doctors about the possible late effects caused by some treatments. See the PDQ summary on Late Effects of Treatment for Childhood Cancer for more information.
Sources: PDQ · Late Effects of Treatment for Childhood Cancer
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.
Sources: clinical trial · standard treatment
Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
Sources: side effects
Clinical trials are taking place in many parts of the country. Information about clinical trials supported by NCI can be found on NCI’s clinical trials search webpage. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.
Sources: clinical trials search · ClinicalTrials.gov
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
As your child goes through treatment, they will have follow-up tests or check-ups. Some tests that were done to diagnose or stage the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.
Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your child's condition has changed or if the cancer has recurred (come back).
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
Treatment of newly diagnosed solid pseudopapillary tumor of the pancreas in children may include the following:
Surgery to remove the tumor. A Whipple procedure may be done for tumors in the head of the pancreas.
Sources: Surgery · Whipple procedure
Chemotherapy for tumors that cannot be removed by surgery or have spread to other parts of the body.
Sources: Chemotherapy
Treatment of newly diagnosed pancreatoblastoma in children may include the following:
Surgery to remove the tumor. A Whipple procedure may be done for tumors in the head of the pancreas.
Chemotherapy may be given to shrink the tumor before surgery. More chemotherapy may be given after surgery for large tumors, tumors that could not initially be removed by surgery, and tumors that have spread to other parts of the body.
Chemotherapy may be given if the tumor does not respond to treatment or comes back.
Sources: respond
Treatment of newly diagnosed islet cell tumors in children may include drugs to treat symptoms caused by hormones and the following:
Sources: islet cell tumors · drugs · symptoms · hormones
Surgery to remove the tumor.
Chemotherapy and targeted therapy (mTOR inhibitor therapy) for tumors that cannot be removed by surgery or that have spread to other parts of the body.
Sources: targeted therapy · mTOR inhibitor · therapy
There are few reported cases of pancreatic carcinoma in children. (See the PDQ summary on Pancreatic Cancer Treatment [Adult] for possible treatment options.)
Sources: pancreatic · carcinoma · PDQ · Pancreatic Cancer Treatment [Adult]
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Source: Childhood Pancreatic Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2021. Captured 2026-09-09.
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
Treatment of recurrent pancreatic cancer in children may include the following:
Sources: recurrent · pancreatic cancer
A clinical trial that checks a sample of the patient's tumor for certain gene changes. The type of targeted therapy that will be given to the patient depends on the type of gene change.
Sources: clinical trial · tumor · gene · targeted therapy
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Pancreatic Cancer
ClinicalTrials.gov recordPancreatic Cancer in children and adolescents
Treatment of Recurrent Childhood Pancreatic Cancer